International Conference of Drug Regulatory Authorities (ICDRA)
Since it was founded in 1980, the International Conference of Drug Regulatory Authorities (ICDRA) has brought together regulatory authorities from WHO Member States to strengthen collaboration and develop international consensus on regulatory priorities. ICDRA provides a unique forum to support and guide regulatory authorities, WHO and international stakeholders in confronting the challenges and highlighting the opportunities of today’s dynamic and innovative regulatory sector.
Delegates from regulatory authorities around the world will participate in an event programme designed to evoke ideas and discussion on the current key priorities in the regulatory environment while also ensuring valuable engagement with leading stakeholders across industry, research as well as healthcare professionals in the open pre-ICDRA conference.
The 18th ICDRA will facilitate focused discussions on quality issues, regulatory reform and strengthening regulatory systems, safety of medical products, substandard and falsified products, access, regulation of clinical trials, regulatory collaboration, harmonization, convergence and reliance, new technologies, regulation of herbal medicines, etc.
The theme of the conference is: Smart Safety surveillance:
A life-cycle approach to promoting safety of medical products.
To the 18th International Conference of Drug Regulatory Authorities (ICDRA)
The Health Products Regulatory Authority (HPRA) and the WHO, are delighted to invite you to Dublin, Ireland, to participate in the 18th International Conference of Drug Regulatory Authorities (ICDRA).
The conference will be held at the Clayton Hotel, Burlington Road, located in the centre of Dublin between 5 – 7 September 2018.
An open pre-conference event will be convened from 3 - 4 September 2018 at the Clayton Hotel, Dublin.
Health Product Regulatory Authority
The Health Products Regulatory Authority is honoured to host the 18th ICDRA and to welcome fellow regulators and leading international stakeholders to participate in one of the largest global gatherings for medical product regulation. The theme of the event is Smart Safety surveillance - A life-cycle approach to promoting safety of medical products, an area in which, we, as a regulator are continuously learning and adapting to the ever advancing technologies and scientific techniques in the health sector. The HPRA looks forward to fostering new and enhancing our long standing collaborations among our regulatory colleagues as we strive to continuously maintain the safety, efficacy and quality of medicines and medical devices for all patients.